Assessing The Treatment Effect in Metabolic Syndrome without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women.
Conclusions-Attaining the treatment target of LDL-Clt;100 mg/dl within multifactorial treatment of MetS by expert clinics, is achievable and beneficial even in patients without diabetes or known CVD. This induces a considerable e-CVD risk reduction in MetS patients. Actual CVD events were negligible, suggesting that e-CVD risk overestimates actual CVD risk in MetS, at least in patients achieving LDL-Clt;100 mg/dl [ClinicalTrials.gov ID: NCT00416741]. PMID: 21476961 [PubMed - as supplied by publisher] (Source: Current Vascular Pharmacology)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div

India's Economic Growth Leaves Human Development in the Dust
Ahead of the Universal Periodic Review (UPR) of India, a coalition of NGOs denounced the gap between the country's growth rate and the rate of poverty, malnutrition and lack of health and sanitation. (Source: IPS Inter Press Service - Health)